Podcast: CELMoDs in Lymphomas
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

Released: July 11, 2024

Expiration: July 10, 2025

Activity

Progress
1
Course Completed

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including:

  • Rationale for targeting CELMoDs in NHL
  • Mechanism of action of CELMoDs
  • Key studies and available efficacy and safety data with investigational CELMoDs in NHL
  • Key ongoing clinical trials of CELMoDs in NHL
  • Strategies to boost NHL clinical trial diversity among underserved communities